Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 13/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974183 | 0.93 | CA2 (0.41) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974747 | 0.89 | PTGS2 (0.42) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974405 | 0.89 | CA1 (0.41) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974732 | 0.88 | PTGS2 (0.41) | PTGS2PTGS1 | |
| SCHEMBL8974228 | 0.87 | KIF11 (0.48) | CA2CA1CA9CA4MAOB | |
| SCHEMBL8974602 | 0.86 | CA2 (0.44) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974838 | 0.86 | PTGS2 (0.53) | CA2CA1CA9MAOAMAOB | |
| SCHEMBL8974356 | 0.85 | CA2 (0.43) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974328 | 0.83 | CA2 (0.41) | CA2CA1CA9CA5ACA5B | |
| SCHEMBL8974752 | 0.83 | PTGS2 (0.44) | PTGS2PTGS1DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576339-A | Pyridyl substituted cyclopentadienes for the treatment of inflamation | HUANG HORNG-CHIH (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |